Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.641 USD -10.26%
Market Cap: 145.8m USD
Have any thoughts about
Vaxart Inc?
Write Note

Vaxart Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vaxart Inc
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Vaxart Inc
NASDAQ:VXRT
Total Current Liabilities
$15.8m
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
-5%
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$43.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$11.7B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$20.3B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$4B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.7B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
24%

See Also

What is Vaxart Inc's Total Current Liabilities?
Total Current Liabilities
15.8m USD

Based on the financial report for Jun 30, 2024, Vaxart Inc's Total Current Liabilities amounts to 15.8m USD.

What is Vaxart Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-5%

Over the last year, the Total Current Liabilities growth was 13%. The average annual Total Current Liabilities growth rates for Vaxart Inc have been 7% over the past three years , 16% over the past five years , and -5% over the past ten years .

Back to Top